AzTrials
AzTrials

Cocaine Use DisorderPhase 1Project 1NCT02174614

The Effect of Cognitive Enhancement as a Precursor to Computer Based Training for Cognitive Behavioral Therapy (CBT4CBT)

A Phase 1 study testing Treatment As Usual (TAU) and TAU plus Rapid Abstinence Initiation (RAI) in people with Cocaine Use Disorder, run by Yale University at 2 sites in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The investigators are conducting a randomized clinical trial of rapid abstinence initiation and cognitive control training as a precursor to our new web-based version of the CBT4CBT (Computer Based Training for Cognitive Behavioral Therapy) program to evaluate its effectiveness relative to standard outpatient… Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Cocaine Use Disorder
What is being tested?
Treatment As Usual (TAU) and TAU plus Rapid Abstinence Initiation (RAI)
Could I receive a placebo?
No, everyone receives an active treatment
How many people
99 participants
Where
2 sitesUnited States
Study dates
Apr 2015to 31 Aug 2020
Phase
Phase 1
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • 18 years of age or older
  • Meet current DSM-5 criteria for cocaine use disorder
  • Are sufficiently stable for 12 weeks of outpatient treatment
  • Are willing to provide locator information for follow-up
  • Are fluent in English
  • Have a 6th grade or higher reading level for completion of assessments

Who cannot join

  • Untreated bipolar or schizophrenic disorder
  • Current suicide risk
  • Have a legal case pending such that incarceration during the 12-week protocol is likely
  • Are physically dependent on alcohol, opioids or benzodiazepines and require detoxification

Trial locations and contacts

2 sites in 1 country.

United States2 sites
  • MCCA

    Bridgeport, Connecticut, 06601

  • MCCA

    New Haven, Connecticut, 06511

Other trials in United States

About this study

The investigators are conducting a randomized clinical trial of rapid abstinence initiation and cognitive control training as a precursor to our new web-based version of the CBT4CBT (Computer Based Training for Cognitive Behavioral Therapy) program to evaluate its effectiveness relative to standard outpatient counseling at the Midwestern Connecticut Council of Alcoholism (MCCA). CCT will be used to assess attention, working memory and inhibitory control and the computer-based training program (CBT4CBT) focuses on teaching basic coping skills, presenting examples of effective use of coping skills in a number of realistic situations in video form, and providing opportunities for patients to practice and review new skills while receiving cocaine abuse treatment.

Read the detailed description

150 cocaine dependent individuals will be randomly assigned to one of 3 conditions delivered over 4 weeks in the context of intensive outpatient treatment. 1. Treatment as Usual (TAU), 2. rapid abstinence initiation (RAI) or 3. computerized cognitive control training with escalating reinforcement for improved performance on training tasks (CCT). All participants will then receive an 8 week trial of CBT4CBT in addition to TAU. Follow up evaluation thru 6 months posttreatment will assess durability and delayed emergence of treatment effects.

Being tested
Treatment As Usual (TAU), TAU plus Rapid Abstinence Initiation (RAI), TAU plus RAI plus Cognitive Control Training (CCT)
Keywords
Cocaine use disorder

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Treatment As Usual (TAU)Behavioural

    Treatment normally offered at this clinic which could include individual or group drug counseling sessions three times per week lasting three hours each time.

  • TAU plus Rapid Abstinence Initiation (RAI)Behavioural

    Treatment normally offered at this clinic which could include individual or group drug counseling sessions three times per week lasting three hours each time PLUS the chance to earn money for urine specimens that are negative for cocaine during the first 4 weeks of treatment followed by 8 weeks of CBT4CBT computerized therapy.

  • TAU plus RAI plus Cognitive Control Training (CCT)Behavioural

    Treatment normally offered at this clinic which could include individual or group drug counseling sessions three times per week lasting three hours each time PLUS the chance to earn money for urine specimens that are negative for cocaine during the first 4 weeks of treatment PLUS sessions of computerized cognitive control training (CCT) 3 times per week for the first 4 weeks followed by 8 weeks of CBT4CBT computerized therapy.

Study groups in NCT02174614
Study groupRoleWhat they receive
Treatment As Usual (TAU)Active comparatorTreatment normally offered at this clinic which could include individual or group drug counseling sessions three times per week lasting three hours each time.
Receives: Behavioral: Treatment As Usual (TAU)
TAU plus Rapid Abstinence Initiation (RAI)ExperimentalTreatment normally offered at this clinic which could include individual or group drug counseling sessions three times per week lasting three hours each time PLUS the chance to earn money for urine specimens that are negative for cocaine during the first 4 weeks of treatment
Receives: Behavioral: Treatment As Usual (TAU); Behavioral: TAU plus Rapid Abstinence Initiation (RAI)
TAU plus RAI plus Cognitive Control Training (CCT)ExperimentalTreatment normally offered at this clinic which could include individual or group drug counseling sessions three times per week lasting three hours each time PLUS the chance to earn money for urine specimens that are negative for cocaine during the first 4 weeks of treatment PLUS sessions of computerized games 3 times per week for the first 4 weeks.
Receives: Behavioral: Treatment As Usual (TAU); Behavioral: TAU plus Rapid Abstinence Initiation (RAI); Behavioral: TAU plus RAI plus Cognitive Control Training (CCT)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Reduction in cocaine use

    Using urine and breathalyzer screening for negative cocaine and alcohol testing.

    Measured: 12 weeks

Secondary outcomes (1)
  1. Subjects ability to demonstrate coping skills acquisition through a computerized role-playing evaluation

    Use of CBT4CBT program with acquisition of skills demonstrated through homework assignments.

    Measured: 12 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted25 Jun 2014 (estimated)
  2. Study startApr 2015
  3. Primary completion31 Aug 2020
  4. Study completion31 Aug 2020

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 1
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
99 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02174614
Sponsor's protocol ID
1405013937
Other IDs
2P50DA009241-21
Acronym
Project 1
Status last verified
Oct 2020
First submitted
23 Jun 2014
Last updated
14 Oct 2020
Results posted
No
Data monitoring committee
Yes

Questions about this trial

What is this clinical trial studying?

A Phase 1 study testing Treatment As Usual (TAU) and TAU plus Rapid Abstinence Initiation (RAI) in people with Cocaine Use Disorder, run by Yale University at 2 sites in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 14 Oct 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 1 studies test a treatment in a small group of people for the first time or in a new way, mainly to check safety and find the right dose.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Reduction in cocaine use (time frame: 12 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Oct 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in